Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Operating Leases (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Operating Leases for 3 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 69.27% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 69.27% year-over-year, with the annual reading at $1.7 million for FY2025, 69.27% down from the prior year.
  • Operating Leases hit $1.7 million in Q4 2025 for Camp4 Therapeutics, down from $6.3 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $8.5 million in Q4 2023 to a low of $1.7 million in Q4 2025.
  • Historically, Operating Leases has averaged $6.1 million across 3 years, with a median of $6.3 million in 2024.
  • Biggest YoY gain for Operating Leases was 0.03% in 2025; the steepest drop was 69.27% in 2025.
  • Year by year, Operating Leases stood at $8.5 million in 2023, then crashed by 35.28% to $5.5 million in 2024, then crashed by 69.27% to $1.7 million in 2025.
  • Business Quant data shows Operating Leases for CAMP at $1.7 million in Q4 2025, $6.3 million in Q3 2025, and $7.0 million in Q2 2025.